President and CEO,Workers Comp of Coventry Health Care Inc. (CVH) David Wayne Young sells 4,045 shares of CVH on 11/15/2010 at an average price of $25.7 a share.

Coventry Health Care Inc. has a market cap of $3.79 billion; its shares were traded at around $25.51 with a P/E ratio of 7.3 and P/S ratio of 0.3. Coventry Health Care Inc. had an annual average earning growth of 28% over the past 10 years. GuruFocus rated Coventry Health Care Inc. the business predictability rank of 2.5-star.

CVH is in the portfolios of Edward Owens of Vanguard Health Care Fund, Jeff Auxier of Auxier Focus Fund, James Barrow of Barrow, Hanley, Mewhinney & Strauss, Paul Tudor Jones of The Tudor Group, Jim Simons of Renaissance Technologies LLC, Bruce Kovner of Caxton Associates, Steven Cohen of SAC Capital Advisors, Jeremy Grantham of GMO LLC, David Dreman of Dreman Value Management.

This is the annual revenues and earnings per share of CVH over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of CVH.

CEO Recent Trades:

• Sell: CEO Allen F Wise sold 250,000 shares of CVH stock on 11/10/2010 at the average price of 25.79. Allen F Wise owns at least 116,865 shares after this. The price of the stock has decreased by 1.09% since.

CFO Recent Trades:

• Sell: SVP and Interim CFO John J Stelben sold 15,000 shares of CVH stock on 11/10/2010 at the average price of 25.53. John J Stelben owns at least 230,630 shares after this. The price of the stock has decreased by 0.08% since.


• Sell: SVP and Interim CFO John J Stelben sold 5,000 shares of CVH stock on 11/09/2010 at the average price of 26.49. John J Stelben owns at least 245,630 shares after this. The price of the stock has decreased by 3.7% since.

This is the insider trade history vs. stock price of CVH. For the complete insider trading history of CVH, click here.

Directors and Officers Recent Trades:

• Sell: Sr. VP and Controller John J Ruhlmann sold 1,117 shares of CVH stock on 11/10/2010 at the average price of 25.82. John J Ruhlmann owns at least 165,910 shares after this. The price of the stock has decreased by 1.2% since.


• Sell: Executive Vice President Harvey C Jr Demovick sold 229,885 shares of CVH stock on 11/09/2010 at the average price of 25.7. Harvey C Jr Demovick owns at least 211,560 shares after this. The price of the stock has decreased by 0.74% since.


• Sell: SVP & Chief HR Officer Patrisha L Davis sold 8,340 shares of CVH stock on 11/09/2010 at the average price of 26.36. Patrisha L Davis owns at least 249,628 shares after this. The price of the stock has decreased by 3.22% since.


• Sell: Executive Vice President Harvey C Jr Demovick sold 57,984 shares of CVH stock on 08/09/2010 at the average price of 21.71. Harvey C Jr Demovick owns at least 901,215 shares after this. The price of the stock has increased by 17.5% since.


• Sell: Sr. VP and Corp. Controller John J Ruhlmann sold 3,205 shares of CVH stock on 06/23/2010 at the average price of 19.39. John J Ruhlmann owns at least 167,386 shares after this. The price of the stock has increased by 31.56% since.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool